Department Name | Source | Finacial Year | Amount Sanctioned | Purpose |
---|
NA | Central | 2020-2021 | 1438800 | With funding from International AIDS Vaccine Initiative-India, C-SHaRP implemented a 12-month multi-site research study that aimed at understanding the perspectives of potential end-users, service providers and policymakers on the factors influencing the acceptability and feasibility of broadly neutralizing antibodies (bNAbs) as HIV prevention products among populations of interest in India. Dr. Venkatesan Chakrapani, MD, PhD, Chairperson, C-SHaRP, is the Co-PI in this study. |
Ministry of Health and Family Welfare | Central | 2020-2021 | 4916595 | C-SHaRP with support from National AIDS Control Organisation is implementing a two-year multi-site research project aimed at developing, implementing and assessing theory-based pilot multi-level interventions (individual, group and institutional levels) to reduce stigma and discrimination faced by men who have sex with men (MSM) and transgender women (TGW) in public health care settings in Chennai and Mumbai. Dr.Venkatesan Chakrapani, MD, PhD, Chairperson, C-SHaRP, is the PI in this study. |
NA | Central | 2020-2021 | 2600543 | With funding from International AIDS Vaccine Initiative, C-SHaRP is implementing a 15-month multi-site research study that aims to understand the current landscape of community engagement practices related to HIV biomedical research; identify and prioritize the gaps and needs from the perspectives of both community representatives and researchers, and co-design new CE solutions to address ethical and instrumental goals towards robust HIV biomedical research. |
NA | Central | 2019-2020 | 165200 | C-SHaRP with support from APCO Worldwide, Mumbai, organised a webinar titled: PrEP and emerging options for HIV prevention. The webinar aimed to inspire productive conversations on PrEP in India. Experts spoke on the global progress in PrEP implementation, PrEP-related research in India, and the role of private healthcare providers in improving PrEP uptake. A total of 118 participants viewed the webinar through the online webinar platform (Zoom meet). |
United Nations Development Programme India | Central | 2019-2020 | 400000 | Along with Postgraduate Institute of Medical Education and Research (PGIMER), C-SHaRP and other partner agencies co-organised a two-day national symposium on Lesbian, Gay, Bisexual, Transgender and Intersex (LGBTI) Health on March 9 and 10, 2019, at the PGIMER, Chandigarh. This symposium aimed at addressing a range of health issues of a spectrum of sexual and gender minorities and intersex people in India. |
NA | Central | 2021-2022 | 3750000 | C-SHaRP with support from International AIDS Vaccine Initiative-India is implementing a one-year multi-site research study that aimed to inform a target product profile (TPP) for next-generation HIV vaccines that is both responsive to the rapidly evolving science as well as informed by end-user perspectives that are representative and inclusive, particularly of the most vulnerable, underserved, and unreached populations. Dr. Venkatesan Chakrapani, MD, PhD, Chairperson, C-SHaRP, is the PI. |
Ministry of Health and Family Welfare | Central | 2022-2023 | 9396151 | C-SHaRP with support from National AIDS Control Organisation is implementing an 18-month multi-site research project aimed at developing, implementing and evaluating a comprehensive HIV prevention and care package for Transgender Women using a syndemic framework in Chennai, Madurai and Mumbai. Dr. Venkatesan Chakrapani, MD, PhD, Chairperson, C-SHaRP, is the PI in this study. |